Search Results - "Uttam, Vivek"

Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection by Tuli, Hardeep Singh, Garg, Vivek Kumar, Bhushan, Sakshi, Uttam, Vivek, Sharma, Uttam, Jain, Aklank, Sak, Katrin, Yadav, Vikas, Lorenzo, Jose M., Dhama, Kuldeep, Behl, Tapan, Sethi, Gautam

“…•microRNAs play critical role in the development of cancer.•microRNAs can regulate various hallmarks of cancer.•Natural flavonoids can modulate microRNAs to…”
Get full text

Circulating long non-coding RNA EWSAT1 acts as a liquid biopsy marker for esophageal squamous cell carcinoma: A pilot study by Uttam, Vivek, Rana, Manjit Kaur, Sharma, Uttam, Singh, Karuna, Jain, Aklank

“…The widespread public health problem of esophageal squamous cell carcinoma (ESCC) is the cause of an increasing number of deaths each year due to delayed…”
Get full text

Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review by Dash, Chinmayee Priyadarsini, Sonowal, Dhruba, Dhaka, Prachi, Yadav, Rohit, Chettri, Dewan, Satapathy, Bibhu Prasad, Sheoran, Pooja, Uttam, Vivek, Jain, Manju, Jain, Aklank

“…Recent advancements in genetic engineering have made it possible to modify Natural Killer (NK) cells to enhance their ability to fight against various cancers,…”
Get full text

The imminent role of microRNAs in salivary adenoid cystic carcinoma by Kumar, Pawan, Kumawat, Ram Kumar, Uttam, Vivek, Behera, Alisha, Rani, Medha, Singh, Neha, Barwal, Tushar Singh, Sharma, Uttam, Jain, Aklank

“…•SACC, a rare salivary gland tumor, has a very high recurrence rate and relatively high mortality due to poor prognosis and diagnosis.•miRNAs play an essential…”
Get full text

The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review by Satapathy, Bibhu Prasad, Sheoran, Pooja, Yadav, Rohit, Chettri, Dewan, Sonowal, Dhruba, Dash, Chinmayee Priyadarsini, Dhaka, Prachi, Uttam, Vivek, Yadav, Ritu, Jain, Manju, Jain, Aklank

“…Currently, therapies such as chimeric antigen receptor-T Cell (CAR-T) and immune checkpoint inhibitors like programmed cell death protein-1 (PD-1) blockers are…”
Get full text

Immune-Related Long Non-Coding RNA Signature Determines Prognosis and Immunotherapeutic Coherence in Esophageal Cancer by Uttam, Vivek, Kapoor, Harmanpreet Singh, Rana, Manjit Kaur, Yadav, Ritu, Prakash, Hridayesh, Jain, Manju, Tuli, Hardeep Singh, Jain, Aklank

“…Aim of this study was to explore the immune-related lncRNAs having prognostic role and establishing risk score model for better prognosis and immunotherapeutic…”
Get full text

The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer by Yadav, Ritu, Khatkar, Rinku, Yap, Kenneth C-H, Kang, Chloe Yun-Hui, Lyu, Juncheng, Singh, Rahul Kumar, Mandal, Surojit, Mohanta, Adrija, Lam, Hiu Yan, Okina, Elena, Kumar, Rajiv Ranjan, Uttam, Vivek, Sharma, Uttam, Jain, Manju, Prakash, Hridayesh, Tuli, Hardeep Singh, Kumar, Alan Prem, Jain, Aklank

“…Lung cancer is a severe challenge to the health care system with intrinsic resistance to first and second-line chemo/radiotherapies. In view of the sterile…”
Get full text

miR-590–5p: A double-edged sword in the oncogenesis process by Barwal, Tushar Singh, Singh, Neha, Sharma, Uttam, Bazala, Sonali, Rani, Medha, Behera, Alisha, Kumawat, Ram Kumar, Kumar, Pawan, Uttam, Vivek, Khandelwal, Akanksha, Barwal, Jyoti, Jain, Manju, Jain, Aklank

“…•miR-590–5p acts as a tumor-suppressor in breast cancer, head and neck cancer, non-small cell lung cancer, and osteosarcoma.•miR-590–5p acts as a oncogene in…”
Get full text

Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs by Sharma, Uttam, Tuli, Hardeep Singh, Uttam, Vivek, Choudhary, Renuka, Sharma, Bunty, Sharma, Ujjawal, Prakash, Hridayesh, Jain, Aklank

“…Despite advanced clinical and translational oncology research, mortality rates are still increasing worldwide. Recently, a class of non-coding RNAs (ncRNAs),…”
Get full text

Application of curcumin nanoformulations to target folic acid receptor in cancer: Recent trends and advances by Hussain, Arif, Kumar, Ajay, Uttam, Vivek, Sharma, Uttam, Sak, Katrin, Saini, Reena V., Saini, Adesh K., Haque, Shafiul, Tuli, Hardeep Singh, Jain, Aklank, Sethi, Gautam

“…Curcumin, derived from turmeric, has a strong anticancer potential known for millennia. The development of this phytochemical as a medicine has been hampered…”
Get full text

The regulatory role of ZFAS1/miRNAs/mRNAs axis in cancer: a systematic review by SINGH, RAHUL KUMAR, MANDAL, SUROJIT, MOHANTA, ADRIJA, YADAV, RITU, KUMAR, RAJIV RANJAN, KHATKAR, RINKU, UTTAM, VIVEK, SHARMA, UTTAM, RANA, MANJIT KAUR, JAIN, MANJU, TULI, HARDEEP SINGH, JAIN, AKLANK

Get full text

The emerging role of miR-320a in lung cancer: a comprehensive review by Mohanta, Adrija, Kumar, Rajiv R, Singh, Rahul K, Mandal, Surojit, Yadav, Ritu, Khatkar, Rinku, Sharma, Uttam, Uttam, Vivek, Rana, Manjit K, Rana, Amrit Ps, Jain, Aklank

“…A specialized biomarker(s) for lung cancer is imperative owing to its high mortality. Continuing our earlier work demonstrating the role of miR-320a as a tumor…”
Get full text